Nanobiotix

Nanobiotix is a nanomedicine company dedicated for the development of novel treatments and new therapeutics evolving based on the combined applications of nanotechnology and biotechnology for the local treatment of cancer. Nanobiotix researches and progresses biopharmaceutical medicine. Nanobiotix offers oncology nanomedicine treatments to control and treat cancer tumors. Bionanotechnology plays a critical role in both tissue engineering and drug delivery. Nanobiotix has improved a fresh class of therapeutics basing on nanoparticles and nanoxray therapeutics. They comprise of inert nanoparticles designed to enter in the tumor cells. They are injected straight through syringe into tumors, after stimulation by the standard dose of radiation, they relieve free radicals which destroys cancer cells. The lead product of the nanobiotix is NBTXR3 which is a radiosensitizer composed of hafnium oxide nanoparticles.

  • Nanosponges as drug delivery in cancer
  • Hafnium Oxide Nanoparticles(NBTXR3)
  • Polymer capsules as Nanoreactors for therapeutic applications
  • Study of NBTXR3 activated by radiation therapy
  • Nano X-ray technologies
  • NBTXR3 crystalline Nanoparticles

Related Conference of Nanobiotix

May 15-16, 2019

31st Annual Congress on Nanotechnology and Nanomaterials

Prague, Czech Republic
May 20-21, 2019

30th World Nano Conference

Zurich, Switzerland
August 29-31, 2019

31st Nano Congress for Future Advancements

London, UK
September 20-21, 2019

24th Annual Meeting on Nanomaterials Science


San Francisco, California, USA
October 10-11, 2019

32nd International Conference on Advanced Nanotechnology

Dublin, Ireland
October 14-15, 2019

22nd World Nanotechnology Congress

Abu Dhabi, UAE
December 9-10, 2019

3rd World Congress on Nano Science and NanoTechnology

Bangkok,Thailand
May 11-12, 2020

26th World Congress On NanoMaterials and Nanotechnology

Auckland, New Zealand

Nanobiotix Conference Speakers

Recommended Sessions

Related Journals

Are you interested in